$75,000 fellowships available for AI
November 8, 2023
TORONTO – Does your work help answer the question, “How can Digital Technology and Artificial Intelligence change the healthcare we provide”? If you are early to mid-career, have a PhD or a Master’s degree, you can apply to become a Fellow in this field.
Study ways to integrate modern technology and compassionate care, so you can shape the delivery of healthcare services, education of health professionals as well as facilitating the leadership needed to realize the promise of technology. This program requires a supervisor and a mentor located at a Canadian institution.
AMS Healthcare and OSSU are supporting 12 one-year fellowships with up to $75,000 each in funding.
We continue to support fellowships focused on the wellbeing and mental health of healthcare providers, patients and caregivers to address the challenges of living and working through the COVID-19 pandemic. AMS is also interested in receiving fellowship applications focused on preparing for the future of a technology (digital and AI) enabled workforce. Funding Opportunities – AMS Healthcare (ams-inc.on.ca)
Key application requirements
Step 1 (open to all):
- A LOI with signatures
- An abbreviated CV
- A letter of support from the sponsoring institution
- Full proposal, by invitation only
When to apply:
Applications open in November 1st, 2023.
The Ontario SPOR Support Unit oversees the application process.
LOI submission deadline is 5:00 pm (eastern time) on Thursday, January 11, 2024.
The Ontario SPOR SUPPORT Unit (OSSU) is a network of 14 leading health Research Centres and 8 Research Initiatives, supported by a Coordinating Centre located in Toronto, that engages researchers, patients and other partners in patient-oriented research to improve the health of Ontarians and the healthcare system. Jointly funded by the Canadian Institutes of Health Research, the Government of Ontario and partner Ontario hospital foundations and institutes, OSSU provides supports such as expertise, infrastructure, training and resources to people conducting patient-oriented research to help implement Canada’s Strategy for Patient-Oriented Research in Ontario. OSSU also funds projects that demonstrate the value of patient-oriented research and how it can leverage OSSU supports to achieve greater impacts. These awards support translational patient-oriented research that are Innovative, Measurable, Patient-oriented, Appropriate, Collaborative and Transformative – IMPACT Awards. OSSU helps researcher teams conduct patient-oriented research through a network of 14 leading Research Centres located in Ontario that offer a wide range of expertise. OSSU provides infrastructure, expertise and support to people engaged in patient-oriented research, promotes knowledge transfer and exchange of the latest research evidence and aims to improve health policy and clinical practices in Ontario. We are one of 11 SUPPORT Units across the country that form part of the Strategy for Patient Oriented Research.
The AMS Healthcare Vision Endures
AMS Healthcare is a Canadian charitable organization that was created 85 years ago to catalyze change in healthcare. We have impacted healthcare through the introduction of new ideas into the system, particularly focused on the responsibility of providers and healthcare organizations to meet emerging societal needs. Since 2012, AMS Healthcare has focused its vision on the concept of compassionate care: supporting healthcare providers, educators, policy makers and system leaders in anticipating, teaching, and instilling a foundation of compassion at the heart of our health system. This is based on the premise that health professionals provide the best care when they can balance human compassion and technical expertise. Our sweet spot is building leaders committed to compassion in care. Our strength is developing health system leadership – leadership grounded in compassionate care. We should also not lose sight of the learnings afforded by lessons of the past – this was affirmed for all in the collective response to COVID.